Losartan Potassium

Losartan Potassium is used to treat diabetic nephropathies, heart failure, hypertension, left ventricular hypertrophy and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification. The brand product was first FDA-approved on Apr 14, 1995, and the first generic was approved Apr 6, 2010. FDA's Orange Book lists 51 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $360 million on Losartan Potassium across 36.3 million claims for 8.9 million beneficiaries.

Losartan Potassium is available as 120 NDCs from 19 manufacturers (115 generic, 5 brand), with NADAC prices from $0.02 to $6.14 per EA — the most expensive product costs about 290× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.